BMW extends joint venture with BMW Brilliance Automotive Ltd in China
14 Feb 2022|170 views
The BMW Group is underlining its long-term commitment in China with an extension of the joint venture contract with BMW Brilliance Automotive Ltd. (BBA) until 2040.
As part of the new contract, the BMW Group is also increasing its stake in BBA to 75%, while its Chinese partner, Brilliance China Automotive Holdings Ltd. (CBA), indirectly holds the remaining 25%.
BBA is also increasing production capacity in Shenyang this year, with its plant in the Dadong district currently undergoing a comprehensive expansion, while a completely new plant is also being built in the Tiexi district. The BMW Group will use the additional capacity to locally manufacture models for the Chinese market, which are also being produced in other plants. It will also be used to manufacture additional fully electric models in China.
Last year, a total of 846,237 BMW Group vehicles were delivered to customers in the Chinese market (an 8.9% growth when compared against 2020). In 2021, BBA produced more than 700,000 BMW vehicles, with around 23,000 employees.
As part of the new contract, the BMW Group is also increasing its stake in BBA to 75%, while its Chinese partner, Brilliance China Automotive Holdings Ltd. (CBA), indirectly holds the remaining 25%.
BBA is also increasing production capacity in Shenyang this year, with its plant in the Dadong district currently undergoing a comprehensive expansion, while a completely new plant is also being built in the Tiexi district. The BMW Group will use the additional capacity to locally manufacture models for the Chinese market, which are also being produced in other plants. It will also be used to manufacture additional fully electric models in China.
Last year, a total of 846,237 BMW Group vehicles were delivered to customers in the Chinese market (an 8.9% growth when compared against 2020). In 2021, BBA produced more than 700,000 BMW vehicles, with around 23,000 employees.
The BMW Group is underlining its long-term commitment in China with an extension of the joint venture contract with BMW Brilliance Automotive Ltd. (BBA) until 2040.
As part of the new contract, the BMW Group is also increasing its stake in BBA to 75%, while its Chinese partner, Brilliance China Automotive Holdings Ltd. (CBA), indirectly holds the remaining 25%.
BBA is also increasing production capacity in Shenyang this year, with its plant in the Dadong district currently undergoing a comprehensive expansion, while a completely new plant is also being built in the Tiexi district. The BMW Group will use the additional capacity to locally manufacture models for the Chinese market, which are also being produced in other plants. It will also be used to manufacture additional fully electric models in China.
Last year, a total of 846,237 BMW Group vehicles were delivered to customers in the Chinese market (an 8.9% growth when compared against 2020). In 2021, BBA produced more than 700,000 BMW vehicles, with around 23,000 employees.
As part of the new contract, the BMW Group is also increasing its stake in BBA to 75%, while its Chinese partner, Brilliance China Automotive Holdings Ltd. (CBA), indirectly holds the remaining 25%.
BBA is also increasing production capacity in Shenyang this year, with its plant in the Dadong district currently undergoing a comprehensive expansion, while a completely new plant is also being built in the Tiexi district. The BMW Group will use the additional capacity to locally manufacture models for the Chinese market, which are also being produced in other plants. It will also be used to manufacture additional fully electric models in China.
Last year, a total of 846,237 BMW Group vehicles were delivered to customers in the Chinese market (an 8.9% growth when compared against 2020). In 2021, BBA produced more than 700,000 BMW vehicles, with around 23,000 employees.
Latest COE Prices
April 2025 | 2nd BIDDING
NEXT TENDER: 07 May 2025
CAT A$99,500
CAT B$117,003
CAT C$65,001
CAT E$118,001
View Full Results Thank You For Your Subscription.